In July 2012, the Food & Drug Administration (FDA) approved a commonly used HIV medication, for use as pre-exposure prophylaxis (PrEP). Taken once daily by HIV-negative individuals, the pill has been shown to prevent HIV acquisition by more than 90 percent.